ISRG
Intuitive Surgical, Inc. · Healthcare · Medical - Instruments & Supplies
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 179 | -1 | 245.69M | $97.96B | +4 | −6 |
| Q1 2026 | 184 | +1 | 243.48M | $112.58B | +4 | −4 |
| Q4 2025 | 182 | 0 | 259.57M | $146.90B | +1 | — |
| Q3 2025 | 29 | +1 | 147.31M | $65.86B | +1 | −1 |
| Q2 2025 | 26 | -1 | 137.54M | $74.72B | — | −1 |
| Q1 2025 | 24 | 0 | 64.33M | $31.85B | — | — |
| Q4 2024 | 24 | 0 | 65.18M | $34.01B | — | — |
| Q3 2024 | 23 | -1 | 49.95M | $24.53B | +1 | −2 |
| Q2 2024 | 24 | — | 52.49M | $23.34B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 15.84M | — | $7.05B | 0.8% | n/c | 1 | SEC ↗ ×2 |
| 2 | Capital World Investors ✦ | 7.35M | — | $3.27B | 0.5% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 7.37M | — | $3.27B | 0.3% | n/c | 1 | SEC ↗ ×2 |
| 4 | Fisher Asset Management ✦ | 4.70M | — | $2.09B | 0.9% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (passive) | 4.41M | — | $1.96B | 0.3% | n/c | 1 | SEC ↗ |
| 6 | Baillie Gifford ✦ | 3.82M | — | $1.70B | 1.3% | n/c | 1 | SEC ↗ ×4 |
| 7 | Wellington Management ✦ | 3.06M | — | $1.36B | 0.2% | n/c | 1 | SEC ↗ ×8 |
| 8 | Millennium Management ✦ | 1.52M | — | $674.71M | 0.6% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.42M | — | $633.14M | 0.6% | n/c | 1 | SEC ↗ |
| 10 | Coatue Management ✦ | 1.03M | — | $456.88M | 1.8% | n/c | 1 | SEC ↗ ×4 |
| 11 | Point72 Asset Management ✦ | 571.47K | — | $254.22M | 0.8% | n/c | 1 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 446.32K | — | $198.55M | 0.4% | n/c | 1 | SEC ↗ |
| 13 | Viking Global Investors ✦ | 337.89K | — | $150.31M | 0.6% | n/c | 1 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 264.04K | — | $117.46M | 0.1% | n/c | 1 | SEC ↗ |
| 15 | Bridgewater Associates ✦ | 103.58K | — | $46.08M | 0.2% | n/c | 1 | SEC ↗ |
| 16 | Marshall Wace ✦ | 73.93K | — | $32.89M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 42.69K | — | $18.96M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 18 | D. E. Shaw & Co. ✦ | 36.69K | — | $16.32M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 19 | ARK Investment Management ✦ | 33.28K | — | $14.80M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Soros Fund Management ✦ | 25.00K | — | $11.12M | 0.3% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 18.71K | — | $8.32M | 0.1% | n/c | 1 | SEC ↗ |
| 22 | GAMCO Investors ✦ | 11.41K | — | $5.08M | 0.1% | n/c | 1 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 2.00K | — | $889,700 | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Dodge & Cox ✦ | 500 | — | $222,425 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,290 holders, 287.87M shares, $124.40B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 543 sh · $203,321
Officer · 546 sh · $204,444
Officer · 25 sh · $9,145
Officer · 23 sh · $7,996
Officer · 23 sh · $8,055
Officer · 46 sh · $16,617
Officer · 77 sh · $28,919
Officer · 77 sh · $30,520
Officer · 77 sh · $30,358
Officer · 77 sh · $30,338
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology